Literature DB >> 25451691

Regulation of vascular tone in rabbit ophthalmic artery: cross talk of endogenous and exogenous gas mediators.

Salvatore Salomone1, Roberta Foresti2, Ambra Villari3, Giovanni Giurdanella3, Filippo Drago3, Claudio Bucolo3.   

Abstract

Nitric oxide (NO), carbon monoxide (CO) and hydrogen sulphide (H2S) modulate vascular tone. In view of their therapeutic potential for ocular diseases, we examined the effect of exogenous CO and H2S on tone of isolated rabbit ophthalmic artery and their interaction with endogenous and exogenous NO. Ophthalmic artery segments mounted on a wire myograph were challenged with cumulative concentrations of phenylephrine (PE) in the presence or absence of NG-nitro-L-arginine (LNNA) to inhibit production of NO, the CO-releasing molecules CORMs or the H2S-donor GYY4137. The maximal vasoconstriction elicited by PE reached 20-30% of that induced by KCl but was dramatically increased by incubation with LNNA. GYY4137 significantly raised PE-mediated vasoconstriction, but it did not change the response to PE in the presence of LNNA or the relaxation to sodium nitroprusside (SNP). CORMs concentration-dependently inhibited PE-induced constriction, an effect that was synergistic with endogenous NO (reduced by LNNA), but insensitive to blockade of guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3,-α]quinoxalin-1-one (ODQ). In vascular tissues cyclic GMP (cGMP) levels seemed reduced by GYY4137 (not significantly), but were not changed by CORM. These data indicate that CO is able per se to relax isolated ophthalmic artery and to synergize with NO, while H2S counteracts the effect of endogenous NO. CO does not stimulate cGMP production in our system, while H2S may reduce cGMP production stimulated by endogenous NO. These findings provide new insights into the complexities of gas interactions in the control of ophthalmic vascular tone, highlighting potential pharmacological targets for ocular diseases.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbon monoxide; Hydrogen sulfide; Nitric oxide; Ophthalmic artery; Vascular tone

Mesh:

Substances:

Year:  2014        PMID: 25451691     DOI: 10.1016/j.bcp.2014.10.011

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  12 in total

1.  Inhibitory action of novel hydrogen sulfide donors on bovine isolated posterior ciliary arteries.

Authors:  Madhura Kulkarni-Chitnis; Ya Fatou Njie-Mbye; Leah Mitchell; Jenaye Robinson; Matthew Whiteman; Mark E Wood; Catherine A Opere; Sunny E Ohia
Journal:  Exp Eye Res       Date:  2015-04-04       Impact factor: 3.467

2.  Comparative Effects of Hydrogen Sulfide-Releasing Compounds on [3H]D-Aspartate Release from Bovine Isolated Retinae.

Authors:  Pratik Bankhele; Ankita Salvi; Jamal Jamil; Fatou Njie-Mbye; Sunny Ohia; Catherine A Opere
Journal:  Neurochem Res       Date:  2018-01-20       Impact factor: 3.996

Review 3.  Regulation of Aqueous Humor Dynamics by Hydrogen Sulfide: Potential Role in Glaucoma Pharmacotherapy.

Authors:  Sunny E Ohia; Jenaye Robinson; Leah Mitchell; Kalu K Ngele; Segewkal Heruye; Catherine A Opere; Ya Fatou Njie-Mbye
Journal:  J Ocul Pharmacol Ther       Date:  2017-12-07       Impact factor: 2.671

4.  Altered transsulfuration pathway enzymes and redox homeostasis in inherited retinal degenerative diseases.

Authors:  Alireza Badiei; William A Beltran; Gustavo D Aguirre
Journal:  Exp Eye Res       Date:  2021-12-23       Impact factor: 3.467

5.  Hydrogen sulfide protects retina from blue light-induced photodamage and degeneration via inhibiting ROS-mediated ER stress-CHOP apoptosis signal.

Authors:  Sen Zhu; Xuan Li; Bingrong Dang; Fen Wu; Kexin Gou; Chunming Wang; Changjun Lin
Journal:  Redox Rep       Date:  2022-12       Impact factor: 5.696

Review 6.  Carbon monoxide as a promising molecule to promote nerve regeneration after traumatic brain injury.

Authors:  Liang Qiao; Ning Zhang; Jun-Long Huang; Xiang-Qun Yang
Journal:  Med Gas Res       Date:  2017-03-30

Review 7.  Novel Therapeutics in Glaucoma Management.

Authors:  Claudio Bucolo; Chiara Bianca Maria Platania; Filippo Drago; Vincenza Bonfiglio; Michele Reibaldi; Teresio Avitabile; Maurizio Uva
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

8.  The Gatekeepers in the Mouse Ophthalmic Artery: Endothelium-Dependent Mechanisms of Cholinergic Vasodilation.

Authors:  Caroline Manicam; Julia Staubitz; Christoph Brochhausen; Franz H Grus; Norbert Pfeiffer; Adrian Gericke
Journal:  Sci Rep       Date:  2016-02-02       Impact factor: 4.379

9.  The Ability of Nitric Oxide to Lower Intraocular Pressure Is Dependent on Guanylyl Cyclase.

Authors:  Stefan Muenster; Wolfgang S Lieb; Gregor Fabry; Kaitlin N Allen; Shivani S Kamat; Ann H Guy; Ana C Dordea; Leandro Teixeira; Robert E Tainsh; Binglan Yu; Wei Zhu; Nicole E Ashpole; Rajeev Malhotra; Peter Brouckaert; Donald B Bloch; Marielle Scherrer-Crosbie; W Daniel Stamer; Markus H Kuehn; Louis R Pasquale; Emmanuel S Buys
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-09-01       Impact factor: 4.799

10.  Apixaban Enhances Vasodilatation Mediated by Protease-Activated Receptor 2 in Isolated Rat Arteries.

Authors:  Ambra Villari; Giovanni Giurdanella; Claudio Bucolo; Filippo Drago; Salvatore Salomone
Journal:  Front Pharmacol       Date:  2017-07-18       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.